• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

(氯-90)/磷酸盐比值在鉴别原发性甲状旁腺功能亢进与其他原因所致高钙血症中的临床应用价值。

Clinical usefulness of the (chloride-90)/phosphate ratio for distinguishing primary hyperparathyroidism from hypercalcemia due to other causes.

作者信息

Higashi K, Morita M, Tajiri J, Sato T, Okazaki K, Arai S

出版信息

Endocrinol Jpn. 1985 Jun;32(3):421-6. doi: 10.1507/endocrj1954.32.421.

DOI:10.1507/endocrj1954.32.421
PMID:4042994
Abstract

In order to obtain a good separation line between patients with primary hyperparathyroidism (1 degree HPT) and those with non-parathyroidal hypercalcemia (NPHC), serum chloride (Cl) and phosphate (P) concentrations were analyzed. Ninety-nine per cent of the patients with 1 degree HPT had a Cl/P ratio greater than or equal to 33, but 29% of patients with NPHC were also included in this range. When the (Cl-90)/P ratio was used to separate into two groups, 98% of the patients with 1 degree HPT had a ratio greater than or equal to 5.0, and 94% of the patients with NPHC had a ratio less than 5.0. From these results, while high sensitivity was achieved both with the Cl/P and (Cl-90)/P ratios, the (Cl-90)/P ratio provided higher specificity. Therefore we conclude that the (Cl-90)/P ratio was excellent in distinguishing 1 degree HPT from other types of hypercalcemia.

摘要

为了在原发性甲状旁腺功能亢进症(1度HPT)患者与非甲状旁腺性高钙血症(NPHC)患者之间获得良好的区分界限,对血清氯(Cl)和磷酸盐(P)浓度进行了分析。99%的1度HPT患者的Cl/P比值大于或等于33,但29%的NPHC患者也在此范围内。当使用(Cl-90)/P比值将患者分为两组时,98%的1度HPT患者的比值大于或等于5.0,94%的NPHC患者的比值小于5.0。从这些结果来看,虽然Cl/P比值和(Cl-90)/P比值都具有较高的敏感性,但(Cl-90)/P比值具有更高的特异性。因此,我们得出结论,(Cl-90)/P比值在区分1度HPT与其他类型的高钙血症方面表现出色。

相似文献

1
Clinical usefulness of the (chloride-90)/phosphate ratio for distinguishing primary hyperparathyroidism from hypercalcemia due to other causes.(氯-90)/磷酸盐比值在鉴别原发性甲状旁腺功能亢进与其他原因所致高钙血症中的临床应用价值。
Endocrinol Jpn. 1985 Jun;32(3):421-6. doi: 10.1507/endocrj1954.32.421.
2
Chloride/phosphate ratio in primary hyperparathyroidism.原发性甲状旁腺功能亢进症中的氯/磷比值
Am Surg. 2004 Jan;70(1):25-8.
3
The chloride phosphate ratio as the screening test for primary hyperparathyroidism.氯磷比作为原发性甲状旁腺功能亢进症的筛查试验。
Horm Metab Res. 1979 Oct;11(10):577-9. doi: 10.1055/s-0028-1092784.
4
Differential diagnosis of hypercalcemia by the chloride/phosphate ratio.
Am J Surg. 1975 Aug;130(2):166-71. doi: 10.1016/0002-9610(75)90365-7.
5
Serum chloride in the differential diagnosis of hypercalcemia.血清氯在高钙血症的鉴别诊断中的作用
Exp Clin Endocrinol. 1991;98(3):179-84. doi: 10.1055/s-0029-1211115.
6
Chloride:phosphate ratio with hypercalcemia secondary to thiazide administration.噻嗪类药物使用继发高钙血症时的氯磷比
J Fam Pract. 1983 Jan;16(1):153-4.
7
Hypercalcemia: serum chloride and phosphate.高钙血症:血清氯和磷酸盐。
Ann Intern Med. 1977 May;86(5):664. doi: 10.7326/0003-4819-86-5-664_1.
8
The chloride-phosphate ratio in hypercalcemia.高钙血症中的氯磷比。
Ann Intern Med. 1974 Feb;80(2):200-4. doi: 10.7326/0003-4819-80-2-200.
9
Hypercalcemia due to primary hyperparathyroidism or malignant disease. Evaluated by means of biochemical tests and the steroid suppression test.原发性甲状旁腺功能亢进或恶性疾病所致的高钙血症。通过生化检查和类固醇抑制试验进行评估。
Acta Med Scand. 1982;212(3):163-6.
10
Letter: Chloride: phosphate and hypercalcemia.信件:氯化物、磷酸盐与高钙血症。
Ann Intern Med. 1974 Aug;81(2):270-1. doi: 10.7326/0003-4819-81-2-270_2.